Literature DB >> 30992322

A Human Organotypic Microfluidic Tumor Model Permits Investigation of the Interplay between Patient-Derived Fibroblasts and Breast Cancer Cells.

Danh D Truong1, Alexander Kratz1, Jin G Park2, Eric S Barrientos1, Harpinder Saini1, Toan Nguyen1, Barbara Pockaj3, Ghassan Mouneimne4, Joshua LaBaer2, Mehdi Nikkhah5.   

Abstract

Tumor-stroma interactions significantly influence cancer cell metastasis and disease progression. These interactions are partly comprised of the cross-talk between tumor and stromal fibroblasts, but the key molecular mechanisms within the cross-talk that govern cancer invasion are still unclear. Here, we adapted our previously developed microfluidic device as a 3D in vitro organotypic model to mechanistically study tumor-stroma interactions by mimicking the spatial organization of the tumor microenvironment on a chip. We cocultured breast cancer and patient-derived fibroblast cells in 3D tumor and stroma regions, respectively, and combined functional assessments, including cancer cell migration, with transcriptome profiling to unveil the molecular influence of tumor-stroma cross-talk on invasion. This led to the observation that cancer-associated fibroblasts (CAF) enhanced invasion in 3D by inducing expression of a novel gene of interest, glycoprotein nonmetastatic B (GPNMB), in breast cancer cells, resulting in increased migration speed. Importantly, knockdown of GPNMB blunted the influence of CAF on enhanced cancer invasion. Overall, these results demonstrate the ability of our model to recapitulate patient-specific tumor microenvironments to investigate the cellular and molecular consequences of tumor-stroma interactions. SIGNIFICANCE: An organotypic model of tumor-stroma interactions on a microfluidic chip reveals that CAFs promote invasion by enhancing expression of GPNMB in breast cancer cells. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 30992322      PMCID: PMC6664809          DOI: 10.1158/0008-5472.CAN-18-2293

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.

Authors:  Akira Orimo; Piyush B Gupta; Dennis C Sgroi; Fernando Arenzana-Seisdedos; Thierry Delaunay; Rizwan Naeem; Vincent J Carey; Andrea L Richardson; Robert A Weinberg
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

2.  Human breast fibroblasts inhibit growth of the MCF10AT xenograft model of proliferative breast disease.

Authors:  Andrea Sadlonova; Shibani Mukherjee; Damon B Bowe; Sandra R Gault; Nicole A Dumas; Brian A Van Tine; Natalya Frolova; Grier P Page; Danny R Welch; Lea Novak; Andra R Frost
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

3.  Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta.

Authors:  Christina H Stuelten; Stacey DaCosta Byfield; Praveen R Arany; Tatiana S Karpova; William G Stetler-Stevenson; Anita B Roberts
Journal:  J Cell Sci       Date:  2005-04-26       Impact factor: 5.285

4.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

Authors:  Richard M Neve; Koei Chin; Jane Fridlyand; Jennifer Yeh; Frederick L Baehner; Tea Fevr; Laura Clark; Nora Bayani; Jean-Philippe Coppe; Frances Tong; Terry Speed; Paul T Spellman; Sandy DeVries; Anna Lapuk; Nick J Wang; Wen-Lin Kuo; Jackie L Stilwell; Daniel Pinkel; Donna G Albertson; Frederic M Waldman; Frank McCormick; Robert B Dickson; Michael D Johnson; Marc Lippman; Stephen Ethier; Adi Gazdar; Joe W Gray
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

5.  TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins.

Authors:  Rachel Anna Evans; Ya Chung Tian; Robert Steadman; Aled Owain Phillips
Journal:  Exp Cell Res       Date:  2003-01-15       Impact factor: 3.905

6.  Osteoactivin promotes breast cancer metastasis to bone.

Authors:  April A N Rose; François Pepin; Caterina Russo; Jad E Abou Khalil; Michael Hallett; Peter M Siegel
Journal:  Mol Cancer Res       Date:  2007-10       Impact factor: 5.852

7.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

8.  Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer.

Authors:  Theresa Casey; Jeffrey Bond; Scott Tighe; Timothy Hunter; Laura Lintault; Osman Patel; Jonathan Eneman; Abigail Crocker; Jeffrey White; Joseph Tessitore; Mary Stanley; Seth Harlow; Donald Weaver; Hyman Muss; Karen Plaut
Journal:  Breast Cancer Res Treat       Date:  2008-03-29       Impact factor: 4.872

9.  X chromosomal abnormalities in basal-like human breast cancer.

Authors:  Andrea L Richardson; Zhigang C Wang; Arcangela De Nicolo; Xin Lu; Myles Brown; Alexander Miron; Xiaodong Liao; J Dirk Iglehart; David M Livingston; Shridar Ganesan
Journal:  Cancer Cell       Date:  2006-02       Impact factor: 31.743

10.  Gene expression profiling of the tumor microenvironment during breast cancer progression.

Authors:  Xiao-Jun Ma; Sonika Dahiya; Elizabeth Richardson; Mark Erlander; Dennis C Sgroi
Journal:  Breast Cancer Res       Date:  2009-02-02       Impact factor: 6.466

View more
  33 in total

Review 1.  Three-dimensional scaffold-free microtissues engineered for cardiac repair.

Authors:  Alejandra Patino-Guerrero; Jaimeson Veldhuizen; Wuqiang Zhu; Raymond Q Migrino; Mehdi Nikkhah
Journal:  J Mater Chem B       Date:  2020-07-29       Impact factor: 6.331

2.  Fabrication Method of a High-Density Co-Culture Tumor-Stroma Platform to Study Cancer Progression.

Authors:  Harpinder Saini; Mehdi Nikkhah
Journal:  Methods Mol Biol       Date:  2021

3.  GPNMB overexpression is associated with extensive bone metastasis and poor prognosis in renal cell carcinoma.

Authors:  Jian-Po Zhai; Zhen-Hua Liu; Hai-Dong Wang; Guang-Lin Huang; Li-Bo Man
Journal:  Oncol Lett       Date:  2021-12-01       Impact factor: 2.967

4.  High-Throughput Tumor-on-a-Chip Platform to Study Tumor-Stroma Interactions and Drug Pharmacokinetics.

Authors:  Chun-Wei Chi; Yeh-Hsing Lao; A H Rezwanuddin Ahmed; Elizabeth C Benoy; Chenghai Li; Zeynep Dereli-Korkut; Bingmei M Fu; Kam W Leong; Sihong Wang
Journal:  Adv Healthc Mater       Date:  2020-09-23       Impact factor: 9.933

Review 5.  Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.

Authors:  Farbod Amirghasemi; Emmanuela Adjei-Sowah; Barbara A Pockaj; Mehdi Nikkhah
Journal:  Ann Biomed Eng       Date:  2021-01-05       Impact factor: 3.934

Review 6.  Breast tumor-on-chip models: From disease modeling to personalized drug screening.

Authors:  Bano Subia; Ujjwal Ranjan Dahiya; Sarita Mishra; Jessica Ayache; Guilhem Velve Casquillas; David Caballero; Rui L Reis; Subhas C Kundu
Journal:  J Control Release       Date:  2021-01-06       Impact factor: 9.776

7.  The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33.

Authors:  M Liguori; E Digifico; A Vacchini; R Avigni; F S Colombo; E M Borroni; F M Farina; S Milanesi; A Castagna; L Mannarino; I Craparotta; S Marchini; E Erba; N Panini; M Tamborini; V Rimoldi; P Allavena; C Belgiovine
Journal:  Cell Mol Immunol       Date:  2020-07-29       Impact factor: 11.530

Review 8.  Engineering Breast Cancer On-chip-Moving Toward Subtype Specific Models.

Authors:  Carmen Moccia; Kristina Haase
Journal:  Front Bioeng Biotechnol       Date:  2021-06-23

9.  Loss of Nitric Oxide Induces Fibrogenic Response in Organotypic 3D Co-Culture of Mammary Epithelia and Fibroblasts-An Indicator for Breast Carcinogenesis.

Authors:  Gang Ren; Xunzhen Zheng; Vandana Sharma; Joshua Letson; Andrea L Nestor-Kalinoski; Saori Furuta
Journal:  Cancers (Basel)       Date:  2021-06-05       Impact factor: 6.639

10.  Human tumor microenvironment chip evaluates the consequences of platelet extravasation and combinatorial antitumor-antiplatelet therapy in ovarian cancer.

Authors:  Biswajit Saha; Tanmay Mathur; James J Tronolone; Mithil Chokshi; Giriraj K Lokhande; Amirali Selahi; Akhilesh K Gaharwar; Vahid Afshar-Kharghan; Anil K Sood; Gang Bao; Abhishek Jain
Journal:  Sci Adv       Date:  2021-07-21       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.